MML enters into new supply agreement with Uruguay’s CCC
Mainstay Medical International’s subsidiary Mainstay Medical Limited (MML) has made a new supply deal with Centro de Construccion de Cardioestimuladores del Uruguay S.A. (CCC)
Pharmaceuticals, Biotechnology and Life Sciences
Mainstay Medical International’s subsidiary Mainstay Medical Limited (MML) has made a new supply deal with Centro de Construccion de Cardioestimuladores del Uruguay S.A. (CCC)
Creso Pharma Limited, the company that Creso Pharma, the company focused on cannabis derived therapeutics, requests that its securities to be placed in a trading halt.
Related to Convertible Note and Warrant Programmes established on September 26, 2016 between the Fit Biotech Oy and Bracknor Investment,…
AIM and Nasdaq listed pharmaceutical company, Hutchison China MediTech Limited (Chi-Med) has initiated two Phase II studies in China for testing cancer treatments.
University of Michigan Pancreatic Cancer Center has become the most recent member of the global network of prominent sites participating…
Safe Orthopaedics has started selling a bone substitute for its Walnut cage for cervical surgeries in Europe.
Horizon Discovery has broadened its gene editing capabilities through the amendment of a pre-existing license with ERS Genomics to include…
M Pharmaceutical will continue develop a patented topical drug product for the treatment of female sexual dysfunction (FSD), as part…
The pharmaceutical industry is typically reluctant to talk about U.S. drug prices, generally the highest in the world due to a combination of market fragmentation and free market policies. But recent high-profile price hikes by Mylan NV, Turing Pharmaceuticals and Valeant Pharmaceuticals International have raised the ire of consumers and lawmakers.
Cervical cancer is highly preventable, yet approximately 530,000 women develop the disease each year worldwide and some 270,000 die from it unnecessarily.